MEDX | XBI | MEDX / XBI | |
Gain YTD | 20.258 | 19.749 | 103% |
Net Assets | 17.9M | 6.94B | 0% |
Total Expense Ratio | 0.85 | 0.35 | 243% |
Turnover | 0.00 | 43.00 | - |
Yield | 1.51 | 0.04 | 3,617% |
Fund Existence | 26 years | 20 years | - |
MEDX | XBI | |
---|---|---|
RSI ODDS (%) | 3 days ago82% | 3 days ago90% |
Stochastic ODDS (%) | 3 days ago77% | 3 days ago90% |
Momentum ODDS (%) | 3 days ago84% | N/A |
MACD ODDS (%) | 3 days ago79% | 3 days ago82% |
TrendWeek ODDS (%) | 3 days ago76% | 3 days ago88% |
TrendMonth ODDS (%) | 3 days ago82% | 3 days ago88% |
Advances ODDS (%) | 4 days ago80% | 10 days ago90% |
Declines ODDS (%) | 24 days ago75% | N/A |
BollingerBands ODDS (%) | 3 days ago81% | 3 days ago90% |
Aroon ODDS (%) | 3 days ago81% | 3 days ago87% |
A.I.dvisor indicates that over the last year, MEDX has been loosely correlated with OGN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if MEDX jumps, then OGN could also see price increases.
Ticker / NAME | Correlation To MEDX | 1D Price Change % | ||
---|---|---|---|---|
MEDX | 100% | +0.13% | ||
OGN - MEDX | 43% Loosely correlated | -1.07% | ||
SNY - MEDX | 40% Loosely correlated | +1.20% | ||
GILD - MEDX | 34% Loosely correlated | +4.21% | ||
REGN - MEDX | 15% Poorly correlated | +1.56% | ||
BCYC - MEDX | 14% Poorly correlated | -5.55% | ||
More |
A.I.dvisor indicates that over the last year, XBI has been closely correlated with IDYA. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if XBI jumps, then IDYA could also see price increases.
Ticker / NAME | Correlation To XBI | 1D Price Change % | ||
---|---|---|---|---|
XBI | 100% | -0.10% | ||
IDYA - XBI | 71% Closely correlated | +5.67% | ||
NUVL - XBI | 71% Closely correlated | +2.32% | ||
BEAM - XBI | 70% Closely correlated | +0.74% | ||
ARWR - XBI | 69% Closely correlated | -5.54% | ||
VRDN - XBI | 69% Closely correlated | +5.22% | ||
More |